Significant proportions of pregnant women living in malaria-endemic countries throughout the world are exposed to the risk of malaria. The World Health Organization (WHO) suggests the use of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) in at least three doses to achieve the optimal benefit of preventing malaria among pregnant women.
The study uses secondary data from the 2016 Ghana Malaria Indicator Survey (GMIS). The analysis included a total of 1220 women aged from 15 to 49 who had children under the age of 24 months and who attended antenatal care (ANC) during their pregnancy. Multinomial logistic regression is used to examine the uptake of partial and optimal doses of IPTp-SP.
The results show that, overall, the proportion of women in Ghana with uptake of IPTp-SP during pregnancy was 63% for three or more doses, 27% for one to two doses, and 10% for no dose. Uptake varies by background characteristics. At the bivariate level, sociodemographic factors (level of education and religion) and knowledge-related factors (exposure to messages on treatment of malaria and covered by health insurance) predicted partial (1–2 doses) or optimal uptake (3+ doses) of IPTp-SP compared to no uptake among pregnant women. The multinomial regression analysis showed that region, education, wealth, and exposure to messages on treatment of malaria are associated with uptake of optimal doses of IPTp-SP compared to partial uptake.
The Ministry of Health, the National Malaria Control Program, Ghana Health Service, and other stakeholders should take cognizance of these factors in planning programs for improving uptake of IPTp-SP among pregnant women. Efforts should be made by stakeholders to increase women’s exposure to mass media messages on the use of IPTp-SP for malaria during pregnancy.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Availability of data and materials
The dataset is available to the public at www.measuredhs.com.
Adebayo AM, Akinyemi OO, Cadmus EO (2015) Knowledge of malaria prevention among pregnant women and female caregivers of under-five children in rural Southwest Nigeria. Peer Journal 3:e792. https://doi.org/10.7717/peerj.792
Akinleye SO, Falade CO, Ajayi IO (2009) Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: A cross-sectional study. BMC Pregnancy Childbirth 9(1):28
Andrew EV, Pell C, Angwin A et al (2014) Factors affecting attendance at and timing of formal antenatal care: results from a qualitative study in Madang, Papua New Guinea. PLoS One 9:e93025
Arthur E (2012) Wealth and antenatal care use: implications for maternal health care utilisation in Ghana. Heal Econ Rev 2:14
Badirou ADB, Georgia PSG, Roméo KM, Luc MOE (2018) Adherence to intermittent preventive treatment of malaria in pregnancy with Sulfadoxine–Pyrimethamine and associated factors: A cross-sectional survey in Benin’s public hospitals. Open Public Health J 11(1):2–15. https://doi.org/10.2174/1874944501811010028
Boateng EY, Anyormi GE, Otoo J, Abaye DA (2018) Drivers of intermittent preventive treatment of malaria during pregnancy in Ghana: A generalized linear model with negative binomial approach. Applied Informatics 5:10 (2018) https://doi.org/10.1186/s40535-018-0057-6
Bosomprah S, Ragno PL, Gros C, Banskota H (2015) Health insurance and maternal, newborn services utilisation and under-five mortality. Arch Public Health 73(1):51. https://doi.org/10.1186/s13690-015-0101-0
Braun V, Rempis E, Schnack A, Decker S, Rubaihayo J, Tumwesigye NM, Theuring S et al (2015) Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in Western Uganda. Malar J 14(1):372. https://doi.org/10.1186/s12936-015-0909-7
Brugiavini A, Pace N (2016) Extending health Insurance in Ghana: effects of the National Health Insurance Scheme on maternity care. Heal Econ Rev 6(1):7. https://doi.org/10.1186/s13561-016-0083-9
Chico RM, Dellicour S, Roman E, Mangiaterra V, Coleman J, Menendez C, Majeres-Lugand M, Webster J, Hill J (2015) Global call to action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa. Malar J 14(1):207. https://doi.org/10.1186/s12936-015-0728-x
Chikwasha V, Phiri I, Chimberengwa P, Bangure D, Rusakaniko S (2014) Predictors of IPTp uptake among pregnant women in the 2010–2011 Zimbabwe Demographic and Health Survey. DHS working papers no. 112 (Zimbabwe working papers no. 13). ICF International, Rockville
Dako-Gyeke M, Kofie HM (2015) Factors influencing prevention and control of malaria among pregnant women resident in urban slums, southern Ghana. Afr J Reprod Health 19(1):44–53
Dapaa S. (2017) Uptake of intermittent preventive treatment for malaria and birth outcomes in selected health facilities in the Brong Ahafo region of Ghana. University of Ghana, Accra. http://ugspace.ug.edu.gh/handle/123456789/23872
Darteh EKM, Acquah E, Darteh F (2017). Why are our children wasting: determinants of wasting among under 5s in Ghana. Nutr Health 23 (3):159–166
Dellicour S, Tatem AJ, Guerra CA, Snow RW, Ter Kuile FO (2010) Quantifying the number of pregnancies at risk of malaria in 2007: A demographic study. PLoS Med 7(1):e1000221. https://doi.org/10.1371/journal.pmed.1000221
Dhiman S, Yadav K, Goswami D, Das N, Baruah I, Singh L (2012). Epidemiology and risk analysis of malaria among pregnant women. Iran J Public Health 41(1):1. https://www.ncbi.nlm.nih.gov/pubmed/23113116
Doku DT, Zankawah MM, Adu-Gyamfi AB (2016) Factors influencing dropout rate of intermittent preventive treatment of malaria during pregnancy. BMC Research Notes 9(460):1–7. https://doi.org/10.1186/s13104-016-2265-2
Exavery A, Mbaruku G, Mbuyita S, Makemba A, Kinyonge IP, Kweka H (2014) Factors affecting uptake of optimal doses of sulphadoxine–pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malar J 13(1):22. https://doi.org/10.1186/1475-2875-13-22
Fullman NR, Burstein SS, Lim C, Medlin GE (2013) Nets, spray or both? The effectiveness of insecticide-treated nets and indoor residual spraying in reducing malaria morbidity and child mortality in sub-Saharan Africa. Malar J 12(1):62. https://doi.org/10.1186/1475-2875-12-62
Ghana Health Service (2016) National Malaria Control Program. Ghana Health Service, Accra. https://www.ghanahealthservice.org/downloads/NMCP_2015_ANNUAL_REPORT.pdf
Ghana Statistical Service (GSS), Ghana Health Service (GHS), and ICF (2017) Ghana Malaria Indicator Survey 2016. GSS, GHS, and ICF, Accra and Rockville, MD, USA
Hemingway J (2014) The role of vector control in stopping the transmission of malaria: threats and opportunities. Philos Trans R Soc Lond B Biol Sci 369(1645):20130431. https://doi.org/10.1098/rstb.2013.0431
Hill J, Hoyt J, van Eijk AM, D'Mello-Guyett L, ter Kuile FO, Steketee R, Smith H, Webster J (2013) Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: A systematic review and meta-analysis. PLoS Med 10(7):e1001488. https://doi.org/10.1371/journal.pmed.1001488
Hill J, Kazembe P (2006) Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Tropical Med Int Health 11(4):409–418. https://doi.org/10.1111/j.1365-3156.2006.01585.x
Holtz A, Couch WH, Fres G, Hamlett T, Hoeppner C, Parker JL, Robblee W, et al (2004). Method, system and computer program product for producing and distributing enhanced media downstreams. Google Patents. https://patents.google.com/patent/US6760916B2/en
Ibrahim H, Maya ET, Issah K, Apanga PA, Bachan EG, Noora CL (2017) Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani municipality, Ghana. PAMJ 28:122. https://doi.org/10.11604/pamj.2017.28.122.12611
Kayentao KP, Garner AM, van Eijk I, Naidoo C, Roper A, Mulokozi JR, MacArthur et al (2013) Intermittent preventive therapy for malaria during pregnancy using 2 Vs 3 or more doses of sulfadoxine–pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. J Am Med Assoc 309(6):594–604. https://doi.org/10.1001/jama.2012.216231
Kemble SK, Davis JC, Nalugwa T, Njama-Meya D, Hopkins H, Dorsey G, Staedke SG (2006) Prevention and treatment strategies used for the Community Management of Childhood Fever in Kampala, Uganda. Am J Trop Med Hyg 74(6):999–1007
Koenker H, Keating J, Alilio M, Acosta A, Lynch M, Nafo-Traore F (2014) Strategic roles for behaviour change communication in a changing malaria landscape. Malar J 13(1):1. https://doi.org/10.1186/1475-2875-13-1
Kumi-Kyereme A, Amu H, Darteh EKM (2017) Barriers and motivations for health insurance subscription in Cape Coast, Ghana: a qualitative study. Arch Public Health 75:24. https://doi.org/10.1186/s13690-017-0192-x
Lassi ZS, Mansoor T, Salam RA, Das JK, Bhutta ZA (2014) Essential pre-pregnancy and pregnancy interventions for improved maternal, newborn and child health. Reprod Health 11(1):S2. https://doi.org/10.1186/1742-4755-11-S1-S2
Mathanga DP, Walker ED, Wilson ML, Ali D, Taylor TE, Laufer MK (2012) Malaria control in Malawi: current status and directions for the future. Acta Trop 121(3):212–217. https://doi.org/10.1016/j.actatropica.2011.06.017
Mbengue MAS, Bei AK, Mboup A et al (2017) Factors influencing the use of malaria prevention strategies by women in Senegal: a crosssectional study. Malar J 16:470
McKenzie S, Droste N, Hickford S, Miller P (2011) Reducing alcohol and other drug-related harm in young people: evaluation of a youth engagement program. Youth Studies Australia 30(4):51
Mensah J, Oppong JR, Schmidt CM (2010) Ghana's National Health Insurance Scheme in the context of the health MDGs: an empirical evaluation using propensity score matching. Health Econ 19(S1):95–106. https://doi.org/10.1002/hec.1633
Ministry of Health (2008). Independence review: health sector programme for work for 2007. Ministry of Health, Accra
Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J (2005) Intermittent preventive treatment of malaria during pregnancy: A qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe district, north-eastern Tanzania. Malar J 4(1):31. https://doi.org/10.1186/1475-2875-4-31
Mubyazi GM, Bloch P (2014) Psychosocial, behavioural and health system barriers to delivery and uptake of intermittent preventive treatment of malaria in pregnancy in Tanzania—viewpoints of service providers in Mkuranga and Mufindi districts. BMC Health Serv Res 14(1):15. https://doi.org/10.1186/1472-6963-14-15
Nganda RY, Drakeley C, Reyburn H, Marchant T (2004) Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. Malar J 3(1):42. https://doi.org/10.1186/1475-2875-3-42
Nwaefuna EK, Afoakwah R, Orish VN, Egyir-Yawson A, Boampong JN (2015) Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine–pyrimethamine against submicroscopic falciparum malaria in Central region, Ghana. J Parasitol Res 2015:959427. https://doi.org/10.1155/2015/959427
Odjidja EN, Kwanin C, Saha M (2017) Low uptake of intermittent preventive treatment in Ghana: an examination of health system bottlenecks. Health Syst Policy Res 4(3):60. https://doi.org/10.21767/2254-9137.100079
Oppong FB, Gyaase S, Zandoh C, Nettey OE, Amenga-Etego S, Anane EA, Adda R, Dosoo DK, Owusu-Agyei S, Asante KP (2019) Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine–pyrimethamine (SP): trends spanning 2011 and 2015. BMJ Open 9(6):e027946. https://doi.org/10.1136/bmjopen-2018-027946
Owusu-Boateng I, Anto F (2017) Intermittent preventive treatment of malaria in pregnancy: A cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana. Malar J 16(1):323. https://doi.org/10.1186/s12936-017-1969-7
Pell C, Meñaca A, Chatio S, Hodgson A, Tagbor H, Pool R (2014) The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in northern Ghana. Malar J 13(1):432. https://doi.org/10.1186/1475-2875-13-432
Pell C, Straus L, Andrew EV, Meñaca A (2011) Pool R. social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: A systematic review of the qualitative research. PLoS One 6(7):e22452. https://doi.org/10.1371/journal.pone.0022452
Sangaré LR, Stergachis A, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Weiss NS (2010) Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda. PLoS One 5(11):e15066. 10.1371/journal.pone.0015066
Sirima SB, Sawadogo R, Moran AC, Konate A, Diarra A, Yameogo M, Parise ME, Newman RD (2003) Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupela district, Burkina Faso. Clin Infect Dis 36(11):1374–1382. https://doi.org/10.1086/375077
Slutsker L, Kachur SP (2013). It is time to rethink tactics in the fight against malaria. Malaria J 12 (1):140. https://doi.org/10.1186/1475-2875-12-140
Snow RW, Amratia P, Kabaria CW, Noor AM, Marsh K (2012) The changing limits and incidence of malaria in Africa: 1939–2009. Adv Parasitol 78:169–262. https://doi.org/10.1016/B978-0-12-394303-3.00010-4
Steketee RW, Nahlen BL, Parise ME, Menendez C (2001) The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 64(1_suppl):28–35
Thornton JA, Rice JL (2008) Determinants of healthcare spending: a state level analysis. Appl Econ 40(22):2873–2889. https://doi.org/10.1080/00036840600993973
United States Agency for International Development (2013). FY2013 Ghana Malaria Operational Plan — President's Malaria Initiative. USAID/Ghana, Accra. https://www.pmi.gov/docs/default-source/default-document-library/malaria-operational-plans/fy13/ghana_mop_fy13.pdf?sfvrsn=8
Wang W, Temsah G, Mallick L (2017) The impact of health insurance on maternal health care utilization: evidence from Ghana, Indonesia and Rwanda. Health Policy Plan 32(3):366–375. https://doi.org/10.1093/heapol/czw135
West PAN, Protopopoff M, Rowland E, Cumming ARC, Drakeley A, Wright et al (2013) Malaria risk factors in North West Tanzania: the effect of spraying, nets and wealth. PLoS One 8(6):e65787. https://doi.org/10.1371/journal.pone.0065787
World Health Organization (2004) A strategic framework for malaria prevention and control during pregnancy in the African region. WHO, Brazzaville. https://www.afro.who.int/sites/default/files/2017-06/malaria_in_pregnancy_092004.pdf
World Health Organization (2005) The roll back malaria strategy for improving access to treatment through home management of malaria. World Health Organization, Geneva, p 2005
World Health Organization (2014) WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine–pyrimethamine (IPTp-Sp). WHO, Geneva. https://www.who.int/malaria/publications/atoz/iptp-sp-updated-policy-brief-24jan2014.pdf?ua=1
World Health Organization (2015a) Roll back malaria partnership malaria in pregnancy working group. Consensus statement on folic acid supplementation during pregnancy. WHO, Geneva.https://www.pmi.gov/docs/default-source/default-document-library/tools-curricula/consensus-statement-folic-acid-supplementation-during-pregnancy.pdf
World Health Organization (2015b) Guidelines for the treatment of malaria. WHO, Geneva. http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf
World Health Organization (2017) World malaria report 2017. WHO, Geneva.https://apps.who.int/iris/bitstream/handle/10665/259492/9789241565523-eng.pdf; jsessionid=37B2D62B09010BA1C88AB2CC5830E7C6? sequence=1
Yaya S, Uthman O, Amouzou A, Bishwajit G (2018) Use of intermittent preventive treatment among pregnant women in sub-Saharan Africa: evidence from malaria Indicator surveys. Trop Med Infect Dis 3(1):18. https://doi.org/10.3390/tropicalmed3010018
Yoder PS, Nsabagasani X, Eckert E, Moran A, Yé Y (2015) Perspectives of health care providers on the provision of intermittent preventive treatment in pregnancy in health facilities in Malawi. BMC Health Serv Res 15(1):354. https://doi.org/10.1186/s12913-015-0986-x
We wish to express our profound gratitude to Wenjuan Wang and Shireen Assaf, who facilitated the 2019 DHS Fellows Program, for their immense contribution to the development of the research project and training on DHS data analysis. We would like to acknowledge the effort of the co-facilitators — Gedefew Abeje Fekadu and Kyaw Swa Mya — for their support during the fellowship. We would like to extend our appreciation to the 2019 DHS fellows for their positive feedback during the training sessions. We also thank the University of Cape Coast for granting us the permission to participate in the DHS 2019 Fellows Program. Our acknowledgment also goes to USAID for funding the research project through ICF. We wish to also thank our reviewer Cameron Taylor for her constructive comments on the paper and support throughout the process.
This study was carried out with support provided by the United States Agency for International Development (USAID) through the DHS Program (#720-OAA-18C-00083). The views expressed are those of the authors and do not necessarily reflect the views of USAID or the United States Government.
Ethical approval and consent to participate
All procedures performed in a study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate is not applicable to our study.
Consent for publication
The authors declare they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Darteh, E.K.M., Buabeng, I. & Akuamoah-Boateng, C. Uptake of intermittent preventive treatment in pregnancy for malaria: further analysis of the 2016 Ghana Malaria Indicator Survey. J Public Health (Berl.) 29, 967–978 (2021). https://doi.org/10.1007/s10389-020-01206-1
- Uptake of intermittent preventive treatment (IPTp-SP)
- Ghana, Malaria Indicator Survey (MIS)